Tumor Cell-Derived Exosomal circ-PRKCI Promotes Proliferation of Renal Cell Carcinoma via Regulating miR-545-3p/CCND1 Axis

Author:

Qian YiguanORCID,Li Yang,Xu Luwei,Chen Ke,Liu Ning,Yang Xiaobing,Lv Qian,Li Rongfei,Zhou Changcheng,Xu Zheng,Jia Ruipeng,Ge Yu-ZhengORCID

Abstract

Renal cell carcinoma (RCC) originates from the epithelial cells of the renal tubules and has a high degree of malignancy and heterogeneity. Recent studies have found that exosomes regulate intercellular communication via transferring various bioactive molecules, such as circular RNAs (circRNAs), which are critical for cancer progression. However, the role of tumor cell-derived exosomal circRNAs in RCC remains unclear. In this study, we reported the high expression of circ-PRKCI in RCC tissues and serum exosomes. We also found that circ-PRKCI could be transferred exosomally from highly malignant RCC cells to relatively less malignant RCC cells. Tumor cell-derived exosomal circ-PRKCI promoted the proliferation, migration, and invasion of RCC cells, while inhibiting their apoptosis. Mechanistically, we found that circ-PRKCI promoted the proliferation of RCC via the miR-545-3p/CCND1 signaling pathway. Our study is the first to report the potential mechanisms of tumor cell-derived exosomal circ-PRKCI in RCC. In conclusion, this study will provide a new understanding about the molecular mechanisms of RCC progression.

Funder

National Natural Science Foundation of China

Science and Technology Foundation of Nanjing Medical University

Natural Science Foundation of Jiangsu Province

Youth Medical Talent Program of Jiangsu Province

Nanjing Medical Science and Technology Development Foundation for Distinguished Young Scholars

“Six Talent Summit” Foundation of Jiangsu Province

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference32 articles.

1. Epidemiology of Renal Cell Carcinoma;Capitanio;Eur. Urol.,2019

2. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

3. Renal cancer;Capitanio;Lancet,2016

4. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance;Bagchi;Annu. Rev. Pathol.,2021

5. Exosomes in Coronary Artery Disease;Gao;Int. J. Biol. Sci.,2019

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3